Prospective Data Collection of Patients With Diffuse Parenchymal Lung Diseases
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01600378 |
Recruitment Status
:
Recruiting
First Posted
: May 17, 2012
Last Update Posted
: November 8, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Diffuse Parenchymal Lung Diseases |
Study Type : | Observational |
Estimated Enrollment : | 500 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Prospective Data Collection of Clinical, Pulmonary Function, Radiological, Bronchoscopic and Fibered Confocal Fluorescence Microscopy Imaging, and Pathological Characteristics in Patients With Diffuse Parenchymal Lung Diseases |
Study Start Date : | May 2012 |
Estimated Primary Completion Date : | April 2022 |
Estimated Study Completion Date : | April 2022 |

- Final diagnoses of patients presenting with diffuse parenchymal lung disease after complete evaluation [ Time Frame: 3 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 90 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- All patients 21 years old and older diagnosed with suspected diffuse parenchymal lung disease (multi-lobar pulmonary infiltrates)
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01600378
Contact: Su Ying Low, BMBCh | +65 63214700 | low.su.ying@sgh.com.sg |
Singapore | |
Singapore General Hospital | Recruiting |
Singapore, Singapore, 169608 | |
Contact: Su Ying Low, BMBCh +65 3214700 low.su.ying@sgh.com.sg | |
Principal Investigator: Su Ying Low, BMBCh |
Principal Investigator: | Su Ying Low, BMBCh | Singapore General Hospital |
Publications:
Responsible Party: | Singapore General Hospital |
ClinicalTrials.gov Identifier: | NCT01600378 History of Changes |
Other Study ID Numbers: |
2012/245/Cilddatabase |
First Posted: | May 17, 2012 Key Record Dates |
Last Update Posted: | November 8, 2017 |
Last Verified: | November 2017 |
Keywords provided by Singapore General Hospital:
diffuse parenchymal lung disease interstitial lung disease idiopathic pulmonary fibrosis |
Additional relevant MeSH terms:
Lung Diseases Lung Diseases, Interstitial Respiratory Tract Diseases |